Juntendo University · Graduate School of Medicine / Faculty of Medicine

Research keywordshematologic malignancies・CAR-T cell therapy・B-cell lymphoma・acute myeloid leukemia・natural killer cell therapy・clinical hematology・myeloproliferative neoplasms

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Suzuki K, Watanabe N, Tsukune Y, Inano T, Kinoshita S, Tomoda S, Yamada K, Konishi Y, Kuwana T, Sugiyama T, Fukada K, Yamada K, Ando M, Takaku T. Artificial intelligence-driven label-free detection of chronic myeloid leukemia cells using ghost cytometry. Sci Rep. 2025; 15: 21046.2025
• Hosoya E, Ando J, Kinoshita S, Furukawa Y, Toyoshima Y, Azusawa Y, Mitsumori T, Sato E, Takano H, Tsukune Y, Watanabe N, Takaku T, Yasuda H, Hamano Y, Sasaki M, Nojiri S, Ishii M, Ando M. Eleven cases of laryngeal edema after tisagenlecleucel infusion: a 3-year single center retrospective study of CD19-directed chimeric antigen receptor T-cell therapy for relapsed and refractory B-cell lymphomas. Haematologica. 2025; 110: 777.2025
• Yanashima K, Furukawa Y, Ishii M, Kinoshita S, Hamano Y, Watanabe N, Tsukune Y, Yasuda H, Ando J, Ando M. Early Epcoritamab Administration Revives CAR-T Cells in Relapsed/Refractory B-Cell Lymphomas. EJHaem. 2025; 6: e70079.2025
• Kaito Y, Sugimoto E, Nakamura F, Tsukune Y, Sasaki M, Yui S, Yamaguchi H, Goyama S, Nannya Y, Mitani K, Tamura H, Imai Y. Immune checkpoint molecule DNAM-1/CD112 axis is a novel target for natural killer-cell therapy in acute myeloid leukemia. Haematologica. 2024; 109: 1107.2024

• Official profile